Deal Announcements & Amendments
2026-11-06 at 10:56am
Armada III (NASDAQ:AACI) has entered into a definitive agreement to combine with drug developer Brains Bioceutical at a pro forma enterprise value of $891.8 million. Brains Bioceutical has built out the manufacturing base to provide medical-grade cannabinoid ingredients to the biotech and consumer industries while pursuing its own potential drug candidates. ...
2026-11-05 at 3:33pm
BHAV I (NASDAQ:BHAV) has entered into a definitive agreement to combine with automated manufacturing firm Nemi Corp. at a pre-money equity value of $400 million. India-based Nemi is developing software and hardware for autonomous manufacturing that it plans to provide as a service to enterprise clients. ...
2026-11-04 at 12:46pm
GP-Act III (NASDAQ:GPAT) has entered into a definitive agreement to combine with cargo drone maker Dronamics at a pro forma enterprise value of $497 million. Dronamics is developing fixed-wing cargo drones for logistics services in both commercial and defense domains. ...
2026-11-02 at 3:18pm
NorthStrive I (NASDAQ:NSAI) has entered into a definitive agreement to combine with nuclear technology firm Nuclea Energy at an enterprise value of $350 million. Mississauga, Canada-based Nuclea is developing molten salt nuclear reactor designs that would be modular and scalable from 3. ...
2026-11-02 at 1:45pm
Starlink AI (NYSE:OTAI) has entered into a definitive agreement to combine with crypto mining firm Spider Digital at a $250 million valuation. Singapore-based Spider Digital provides pooled crypto mining resources and tools for miners and crypto financiers. ...
2026-11-02 at 12:22pm
FG Imperii (NASDAQ:FGII) has entered into a definitive agreement to combine with digital asset firm tZERO at a pro forma enterprise value of $409 million. tZERO provides a platform for tokenizing real world assets and other financial products. ...
2026-10-26 at 12:36pm
Amanat (NASDAQ:AMAN) has entered into a definitive agreement to combine with biotech firm Corxel Pharmaceuticals at an enterprise value of $228 million. Corxel is developing an oral GLP-1 weight-loss drug as well as other potential treatments. ...
2026-10-21 at 1:16pm
APEX Tech (NYSE:TRAD) has entered into a definitive agreement to combine with South Korean film studio Korai Flix at a $3.5 billion pre-money equity value. Korai Flix has launched an online content platform that provides AI-generated short films and allows users to produce their own interactive content with AI avatars. ...
2026-10-19 at 1:04pm
TCGX I (NASDAQ:TCGX) has signed a definitive agreement to combine with drug developer TriGemX Bio at a pro forma enterprise value of $402.8 million. New York-based TriGemX Bio is developing a drug candidate for the treatment of acute migraines that is currently in Phase III trials. ...
2026-10-15 at 12:18pm
Pyrophyte II (NYSE:PAII) has entered into a definitive agreement to combine with manufacturing firm Sakuu at a pro forma enterprise value of $682.3 million. San Jose, California-based Sakuu is developing manufacturing lines for more efficiently producing battery materials for a number of industries. ...